Hemera Biosciences' Angel Round

Hemera Biosciences raised a round of funding on April 01, 2013.

Hemera Biosciences is developing anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration (AMD). AMD is the most common cause of blindness amongst the eld…

Articles about Hemera Biosciences' Angel Round: